Xeris Biopharma Earnings
NASDAQ: XERSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$0.02
Xeris Biopharma earnings summary
Xeris Biopharma is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $0.02. In its most recent report on Aug 6, 2026 (Q2 2026), XERS posted EPS of $-0.18. Revenue for the quarter was $92.1 million.
Across the last 16 reports, XERS shares moved an average of 8.3% (in either direction) in the first trading session after results, rising 8 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
XERS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.18 | — | +8.4% |
| May 7, 2026 | — | $0.01 | — | -4.4% |
| Mar 2, 2026 | — | $0.07 | — | -6.0% |
| Nov 6, 2025 | — | $0.00 | — | -3.4% |
| Aug 7, 2025 | — | $-0.01 | — | +12.3% |
| May 8, 2025 | — | $-0.06 | — | -2.6% |
| Mar 6, 2025 | — | $-0.02 | — | +13.7% |
| Nov 8, 2024 | — | $-0.11 | — | -15.9% |
| Aug 8, 2024 | — | $-0.10 | — | +15.9% |
| May 9, 2024 | — | $-0.14 | — | +12.5% |
| Mar 6, 2024 | — | $-0.10 | — | -5.1% |
| Nov 9, 2023 | — | $-0.09 | — | +4.7% |
| Aug 8, 2023 | — | $-0.14 | — | +4.8% |
| May 9, 2023 | — | $-0.12 | — | 0.0% |
| Mar 8, 2023 | — | $-0.10 | — | +11.6% |
| Nov 9, 2022 | — | $-0.16 | — | -10.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.